116 related articles for article (PubMed ID: 36002506)
1. Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.
Masud SN; Chandrashekhar M; Aregger M; Tan G; Zhang X; Mero P; Pirman DA; Zaslaver O; Smolen GA; Lin ZY; Wong CJ; Boone C; Gingras AC; Montenegro-Burke JR; Moffat J
Nat Chem Biol; 2022 Oct; 18(10):1162. PubMed ID: 36002506
[No Abstract] [Full Text] [Related]
2. Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.
Masud SN; Chandrashekhar M; Aregger M; Tan G; Zhang X; Mero P; Pirman DA; Zaslaver O; Smolen GA; Lin ZY; Wong CJ; Boone C; Gingras AC; Montenegro-Burke JR; Moffat J
Nat Chem Biol; 2022 Dec; 18(12):1370-1379. PubMed ID: 35970996
[TBL] [Abstract][Full Text] [Related]
3. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
4. The binding of the anthelmintic pyrvinium cation to deoxyribonucleic acid in vitro.
Dickie P; Morgan AR; Scraba DG; von Borstel RC
Mol Pharmacol; 1986 Apr; 29(4):427-35. PubMed ID: 3702861
[TBL] [Abstract][Full Text] [Related]
5. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (
Shen C; Li B; Astudillo L; Deutscher MP; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Biochemistry; 2019 Dec; 58(51):5102-5106. PubMed ID: 31820934
[TBL] [Abstract][Full Text] [Related]
6. Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
Li B; Flaveny CA; Giambelli C; Fei DL; Han L; Hang BI; Bai F; Pei XH; Nose V; Burlingame O; Capobianco AJ; Orton D; Lee E; Robbins DJ
PLoS One; 2014; 9(7):e101969. PubMed ID: 25003333
[TBL] [Abstract][Full Text] [Related]
7. High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia.
Wander P; Arentsen-Peters STCJM; Pinhanҫos SS; Koopmans B; Dolman MEM; Ariese R; Bos FL; Castro PG; Jones L; Schneider P; Navarro MG; Molenaar JJ; Rios AC; Zwaan CM; Stam RW
Transl Oncol; 2021 May; 14(5):101048. PubMed ID: 33667892
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pyrvinium, an Anthelmintic Drug, as a Novel Anti-Adipogenic Compound Based on the Gene Expression Microarray and Connectivity Map.
Wang Z; Dai Z; Luo Z; Zuo C
Molecules; 2019 Jun; 24(13):. PubMed ID: 31261664
[TBL] [Abstract][Full Text] [Related]
9. DNA fluorescence induced by polymethine cation pyrvinium binding.
Stockert JC; Trigoso CI; Llorente AR; Del Castillo P
Histochem J; 1991; 23(11-12):548-52. PubMed ID: 1791161
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
Downey AS; Chong CR; Graczyk TK; Sullivan DJ
Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
[TBL] [Abstract][Full Text] [Related]
11. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.
Barbarino M; Cesari D; Intruglio R; Indovina P; Namagerdi A; Bertolino FM; Bottaro M; Rahmani D; Bellan C; Giordano A
J Cell Physiol; 2018 Sep; 233(9):7391-7401. PubMed ID: 29659015
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
Gaikwad VR; Karale UB; Govindarajalu G; Adhikari N; Krishna EV; Krishna VS; Misra S; Sriram D; Sijwali PS; Rode HB
Bioorg Med Chem Lett; 2020 Apr; 30(8):127037. PubMed ID: 32081449
[TBL] [Abstract][Full Text] [Related]
14. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
15. Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells.
Karamian A; Nazarian H; Ziai SA; Zarnani AH; Salehpour S; Paktinat S; Novin MG
Hum Exp Toxicol; 2020 May; 39(5):662-672. PubMed ID: 31880170
[TBL] [Abstract][Full Text] [Related]
16. Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5.
Xiao M; Zhang L; Zhou Y; Rajoria P; Wang C
Biochem Biophys Res Commun; 2016 Jan; 469(3):716-22. PubMed ID: 26707639
[TBL] [Abstract][Full Text] [Related]
17. Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer.
Feng J; Jiang W; Liu Y; Huang W; Hu K; Li K; Chen J; Ma C; Sun Z; Pang X
Biochem Pharmacol; 2020 Jul; 177():113960. PubMed ID: 32298693
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Zheng L; Liu Y; Pan J
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
[TBL] [Abstract][Full Text] [Related]
19. Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration.
Xiang W; Cheong JK; Ang SH; Teo B; Xu P; Asari K; Sun WT; Than H; Bunte RM; Virshup DM; Chuah C
Oncotarget; 2015 Oct; 6(32):33769-80. PubMed ID: 26378050
[TBL] [Abstract][Full Text] [Related]
20. Pyrvinium targets autophagy addiction to promote cancer cell death.
Deng L; Lei Y; Liu R; Li J; Yuan K; Li Y; Chen Y; Liu Y; Lu Y; Edwards CK; Huang C; Wei Y
Cell Death Dis; 2013 May; 4(5):e614. PubMed ID: 23640456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
